Drug Profile
Research programme: oral anti-infective vaccine - Kobe University/Morishita Jintan
Latest Information Update: 11 Jun 2012
Price :
$50
*
At a glance
- Originator Kobe University
- Developer Kobe University; Morishita Jintan
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Phase Unknown Infections
Most Recent Events
- 16 May 2012 Investigation in Infections in Japan (PO)